Sinovac Biotech Ltd. (SVA) Posts Q4 Loss of $0.17; Revs Heavy
Tweet Send to a FriendGet Alerts SVA Hot Sheet
Trade SVA Now!
Sinovac Biotech Ltd. (Nasdaq: SVA) reported Q4 loss of $0.17, which may not compare to the analyst estimate of $0.02. Revenue for the quarter came in at $9.14 million versus the consensus estimate of $8.62 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
- Dick's Sporting Goods, Inc. (DKS) Reports In-Line Q1 EPS; Guides Q2 EPS, Comps
- hhgregg, Inc. (HGG) Tops Q4 EPS by 1c; Guides FY14 EPS
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
